Squarepoint
RDY icon

Squarepoint’s Dr. Reddy's Laboratories RDY Stock Holding History

Squarepoint’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,425
Closed -$269K – 4886
2026
Q1 		$269K Buy
19,425
+1,366
+8% +$19K ﹤0.01% 3789
2025
Q4 		$254K Sell
18,059
-57,577
-76% -$808K ﹤0.01% 3714
2025
Q3 		$1.06M Buy
75,636
+42,332
+127% +$609K ﹤0.01% 2646
2025
Q2 		$501K Sell
33,304
-14,893
-31% -$213K ﹤0.01% 3281
2025
Q1 		$636K Sell
48,197
-15,578
-24% -$215K ﹤0.01% 3071
2024
Q4 		$1.01M Buy
+63,775
New +$958K ﹤0.01% 3056
2024
Q2 		– Sell
-33,090
Closed -$485K – 4543
2024
Q1 		$485K Sell
33,090
-26,445
-44% -$386K ﹤0.01% 3061
2023
Q4 		$828K Buy
+59,535
New +$796K ﹤0.01% 2650
2023
Q3 		– Sell
-27,985
Closed -$353K – 4159
2023
Q2 		$353K Buy
27,985
+5,825
+26% +$68K ﹤0.01% 2860
2023
Q1 		$252K Sell
22,160
-25,985
-54% -$280K ﹤0.01% 2668
2022
Q4 		$498K Buy
+48,145
New +$519K ﹤0.01% 2291
2018
Q3 		– Sell
-43,905
Closed -$283K – 2176
2018
Q2 		$283K Buy
+43,905
New +$277K ﹤0.01% 1412

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Squarepoint's RDY Position: Q2 2026 in Review

Squarepoint sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 19,425 shares — an estimated $269K sold.

Squarepoint first reported a position in RDY in Q2 2018 and held it in 12 quarters. The position peaked at $1.06M in Q3 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Squarepoint reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 19,425 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $269K.
  • Squarepoint first reported a position in Dr. Reddy's Laboratories in Q2 2018 and held it in 12 quarters.
  • Squarepoint's Dr. Reddy's Laboratories position peaked at $1.06M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.